PepJunkie Home of the Peptonauts
More

Peptide Atlas · Mineral

Iron sucrose

In anemic patients with non-dialysis chronic kidney disease, 1 g of intravenous iron sucrose raised hemoglobin by at least 1 g/dL in more patients than oral ferrous sulfate (44.3% against 28.0%).

What the evidence says

six tiers, never blended

established — replicated in humans, or settled by a regulator

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

    • emerging
      Claim: Iron sucrose improved exercise capacity in heart failure with iron deficiency (FERRIC-HF, n=35) standing
    • resolved

    Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.

    Okonko DO, Grzeslo A, Witkowski T, Mandal AK, Slater RM, Roughton M, Foldes G, Thum T, Majda J, Banasiak W, Missouris CG, Poole-Wilson PA, Anker SD, Ponikowski P

    pmid 18191732

    • established
      Claim: Intravenous iron sucrose outperformed oral iron in non-dialysis CKD anemia (RCT) standing
    • resolved

    A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD.

    Van Wyck DB, Roppolo M, Martinez CO, Mazey RM, McMurray S, United States Iron Sucrose (Venofer) Clinical Trials Group

    pmid 16316362

A claim's standing is its latest row in an append-only history; a tombstone names the later evidence and the reason. The Graveyard and the Resurrection Yard.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.